Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
Year: 2020
Type: article
Source: JACC Heart Failure
Authors: William T. Abraham, Mitchell A. Psotka, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Roxana Mehran, Amrut V. Ambardekar, Peter E. Carson, Richard Jacob, James L. Januzzi, Marvin A. Konstam, Mitchell W. Krucoff, Eldrin F. Lewis, Jonathan P. Piccini, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, Ellis F. Unger, Emily P. Zeitler, Stefan D. Anker, Christopher M. O’Connor
Institutions: The Ohio State University, Inova Health System, Duke Medical Center, University of Cyprus, Vanderbilt University, Vanderbilt University Medical Center, Icahn School of Medicine at Mount Sinai, United States Department of Veterans Affairs, Veterans Health Administration, Washington DC VA Medical Center, Massachusetts General Hospital, Baim Institute for Clinical Research, Tufts Medical Center, Stanford University, Brigham and Women's Hospital, United States Food and Drug Administration, San Francisco VA Medical Center, University of California, San Francisco, Dartmouth–Hitchcock Medical Center, Berlin-Brandenburger Centrum für Regenerative Therapien, German Centre for Cardiovascular Research, Charité - Universitätsmedizin Berlin
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Heart Association, Boehringer Ingelheim, Abbott Laboratories, Amgen, Bristol-Myers Squibb, AstraZeneca, Bayer, GlaxoSmithKline, Novartis, Medtronic, Center for Social Inclusion, Gilead Sciences, Edwards Lifesciences, Novartis Pharmaceuticals Corporation, Boston Scientific Corporation, Cytokinetics, Medicines Company, Siemens Medical Solutions USA, Biotronik, OrbusNeich, National Institutes of Health, U.S. Food and Drug Administration, St. Jude Medical, Abbott Vascular, Sanofi Pasteur, Respicardia, National Heart, Lung, and Blood Institute, Janssen Pharmaceuticals
Award: G72586386
OpenAlex ID: W3098830274